NJ Joins $26B Opioid Settlement With J&J, Pharma Cos.
New Jersey intends to join a $26 billion settlement with Johnson & Johnson and three pharmaceutical distribution companies in sprawling multidistrict litigation over the companies' roles in the opioid crisis, acting...To view the full article, register now.
Already a subscriber? Click here to view full article